Janone (ALTS) Stock Price, News & Analysis

Company Overview

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

Key Stats

• Today's Range: $2.16 to $2.39
• 50-Day Range: $1.69 to $2.82
• 52-Week Range: $0.36 to $5.26
• Volume: 145,258 shs
• Average Volume: 237,165 shs
• Market Capitalization: $30.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Janone Stock Analysis - MarketRank™

Janone scored higher than 13% of companies evaluated by MarketBeat, and ranked 836th out of 922 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Janone.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Janone has a P/B Ratio of 8.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.13% of the float of Janone has been sold short.

Short Interest Ratio / Days to Cover

Janone has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Janone has recently decreased by 39.29%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Janone does not currently pay a dividend.

Dividend Growth

Janone does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.13% of the float of Janone has been sold short.

Short Interest Ratio / Days to Cover

Janone has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Janone has recently decreased by 39.29%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for ALTS on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Janone insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,300.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 4.90% of the stock of Janone is held by insiders.

Percentage Held by Institutions

Only 6.27% of the stock of Janone is held by institutions.

ALTS Stock Analysis - Frequently Asked Questions

How have ALTS shares performed this year?

Janone's stock was trading at $2.20 on January 1st, 2024. Since then, ALTS stock has decreased by 0.5% and is now trading at $2.19.
View the best growth stocks for 2024 here.

How do I buy shares of Janone?

Shares of ALTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Janone own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Janone investors own include JIADE (JDZG), Hyzon Motors (HYZN), New Horizon Aircraft (HOVR), Hour Loop (HOUR), Gossamer Bio (GOSS), Genius Group (GNS) and Ford Motor (F).

Company Calendar

• Today: 11/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ALTS
• Previous Symbol: NASDAQ:ALTS
• CUSIP: N/A
• CIK: 862861
• Web: N/A
• Phone: (702) 997-5968
• Fax: 952-930-1800
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,810,000.00
• Net Margins: N/A
• Pretax Margin: -312.94%
• Return on Equity: -2,940.01%
• Return on Assets: -39.81%

Debt

• Debt-to-Equity Ratio: 1.96
• Current Ratio: 0.75
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: $7.11 million
• Price / Sales: 4.33
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.26 per share
• Price / Book: 8.42

Miscellaneous

• Outstanding Shares: 14,069,000
• Free Float: 13,380,000
• Market Cap: $30.81 million
• Optionable: N/A
• Beta: 2.15